Analysts at Piper Jaffray upgraded ICU MedicalICUI
from Neutral to Overweight. The price target for ICU Medical has been raised from $60.00 to $86.00. ICU Medical shares have gained 15.67% over the past 52 weeks, while the S&P 500 index has surged 15.31% in the same period. ICU Medical's shares rose 7.94% to $77.51 in pre-market trading.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.